In the context of engineering CAR T cells, the overexpression of canonical AP-1 factor c-Jun has enhanced T cell expansion potential, increased functional capacity, and improved anti-tumor response in multiple in vivo mouse tumor models (205). The gene discussed is JUN; the disease is neoplasm.